DMII · Drugs Made In America Acquisition II Corp. · Documents
$10.17
-0.01 (-0.05%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$647.19M
Shares
63.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 10-K | 2026-04-15 | 2025-12-31 | |
| 8-K | 2026-04-03 | 2026-03-24 | |
| 8-K | 2026-03-17 | 2026-03-11 | |
| 8-K | 2026-03-06 | 2026-02-28 | |
| 8-K | 2026-03-06 | — | |
| 10-Q | 2025-11-18 | 2025-09-30 | |
| 8-K | 2025-11-18 | 2025-10-08 | |
| 8-K | 2025-10-02 | 2025-09-26 | |
| 8-K | 2025-09-29 | 2025-09-24 |
Showing 1–12 of 12 filings
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
2 filings
2 filers